Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor
May 2001
Wyeth will soon market Protonix IV (pantoprazole), the first INTRAVENOUS proton pump inhibitor.
Until now, hospitalized patients who couldn't take an oral proton pump inhibitor had to get an intravenous H2-blocker.
Protonix IV is officially approved only for short-term treatment in GERD patients...but it will be used for other patients who can't take oral acid-suppressing drugs.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote